Citadel Advisors’s Entera Bio ENTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.1K | Buy |
+11,656
| New | +$22.1K | ﹤0.01% | 5627 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6195 |
|
|
2024
Q4 | – | Sell |
-20,553
| Closed | -$39.1K | – | 6179 |
|
|
2024
Q3 | $39.1K | Buy |
+20,553
| New | +$39.1K | ﹤0.01% | 5181 |
|
|
2024
Q2 | – | Sell |
-12,502
| Closed | -$20.9K | – | 6138 |
|
|
2024
Q1 | $20.9K | Buy |
+12,502
| New | +$20.9K | ﹤0.01% | 5539 |
|
|
2023
Q4 | – | Sell |
-15,368
| Closed | -$11.1K | – | 6080 |
|
|
2023
Q3 | $11.1K | Buy |
15,368
+15,336
| +47,925% | +$11.1K | ﹤0.01% | 5420 |
|
|
2023
Q2 | $27 | Buy |
+32
| New | +$27 | ﹤0.01% | 5728 |
|
|
2023
Q1 | – | Sell |
-30,465
| Closed | -$22.2K | – | 6061 |
|
|
2022
Q4 | $22.2K | Buy |
+30,465
| New | +$22.2K | ﹤0.01% | 5537 |
|
|
2022
Q3 | – | Sell |
-12,657
| Closed | -$17K | – | 6087 |
|
|
2022
Q2 | $17K | Sell |
12,657
-2,400
| -16% | -$3.22K | ﹤0.01% | 5743 |
|
|
2022
Q1 | $43K | Sell |
15,057
-12,531
| -45% | -$35.8K | ﹤0.01% | 5955 |
|
|
2021
Q4 | $78K | Sell |
27,588
-12,270
| -31% | -$34.7K | ﹤0.01% | 6021 |
|
|
2021
Q3 | $188K | Sell |
39,858
-27,312
| -41% | -$129K | ﹤0.01% | 5465 |
|
|
2021
Q2 | $402K | Buy |
+67,170
| New | +$402K | ﹤0.01% | 4920 |
|
|
2020
Q4 | – | Sell |
-22,020
| Closed | -$28K | – | 5182 |
|
|
2020
Q3 | $28K | Buy |
+22,020
| New | +$28K | ﹤0.01% | 4489 |
|